The way of SARS-CoV-2 vaccine development: success and challenges
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). To halt the pandemic, multiple SARS-CoV-2 vaccines have been developed and several have been allowed for emergency use and rollout worldwide. With novel SARS-CoV-2 var...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Publishing Group
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/b5e9d063126f4948b1f5c2cde8276777 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|